Norris Medicines Reports Q2 FY27 Financial Results
Norris Medicines Ltd · Financial Result · 14 Nov 2026, 11:42 pm
Norris Medicines Reports Q2 FY27 Financial Results Norris Medicines reported revenue from operations of ₹65.65 lakhs for the quarter ended 30th Sep'26, down 67.18% YoY from ₹200.04 lakhs and down 28.97% QoQ from ₹92.49 lakhs. Net loss for the quarter narrowed to ₹36.22 lakhs compared to a loss of ₹71.82 lakhs in 30th Sep'25 and ₹39.68 lakhs in 30th Jun'26. Basic and diluted EPS stood at negative ₹0.36 versus negative ₹0.72 YoY. For the six months ended 30th Sep'26, revenue stood at ₹158.14 lakhs with a net loss of ₹75.90 lakhs.
Original exchange filing (PDF)
More announcements from Norris Medicines Ltd
- Outcome Of Board Meeting Held Today I.E. Saturday, November 14, 2026 · 14 Nov 2026
- Norris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Un-Audited Financial Results .... · 14 Nov 2026
- Scrutinizer''s Report and Voting Results of the 35th Annual General Meeting of the Company held on Tuesday 29th September, 2026 · 30 Sept 2026
- Scrutinizer''s Report and Voting Results of the 35th Annual General Meeting of the Company held on Tuesday 29th September, 2026 · 30 Sept 2026
- Outcome and proceeding of the 35th Annual General Meeting of the Company held on Tuesday 29th September, 2026 · 29 Sept 2026
- Outcome and proceeding of the 35th Annual General Meeting of the Company held on Tuesday 29th September, 2026 · 29 Sept 2026
- Outcome of 35th Annual General Meeting of the Company held on Tuesday, 29th September, 2026 · 29 Sept 2026
- Annual Report of the Company for the Financial year 2025-26. · 05 Sept 2026
